MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

Search

Elevance Health Inc

Fechado

SetorSaúde

429.34 -0.87

Visão Geral

Variação de preço das ações

24h

Atual

Mín

426.12

Máximo

430.9

Indicadores-chave

By Trading Economics

Rendimento

-603M

413M

Vendas

742M

45B

P/E

Médio do Setor

16.951

63.778

EPS

3.84

Rendimento de Dividendos

1.57

Margem de lucro

0.909

Funcionários

104,200

EBITDA

1B

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+10.03% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

1.57%

2.39%

Próximos Ganhos

22 de abr. de 2025

Próxima data de dividendos

24 de jun. de 2025

Próxima data de ex-dividendo

9 de jun. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

7.1B

99B

Abertura anterior

430.21

Fecho anterior

429.34

Sentimento de Notícias

By Acuity

37%

63%

130 / 386 Ranking em Healthcare

Elevance Health Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

23 de jan. de 2025, 11:52 UTC

Ganhos

Elevance Health Expects Higher Revenue, Profit in 2025

17 de out. de 2024, 10:49 UTC

Ganhos

Elevance Health 3Q Revenue Beats Estimates Amid Medicaid-Related Challenges

3 de fev. de 2025, 17:56 UTC

Principais Notícias

Trump's Medicaid Comments on Friday Provide Relief for Insurers -- WSJ

23 de jan. de 2025, 14:54 UTC

Ganhos

Elevance Earnings: Stock Rises After Results and Guidance Match Expectations -- WSJ

23 de jan. de 2025, 14:54 UTC

Ganhos

Elevance Stock Gains After Strong Quarter. A Dividend Hike Is Another Positive. -- Barrons.com

23 de jan. de 2025, 12:35 UTC

Ganhos

Elevance Stock Gains After Strong Quarter. A Dividend Hike Is Another Positive. -- Barrons.com

23 de jan. de 2025, 11:02 UTC

Ganhos

Elevance Health Raises Dividend to $1.71 >ELV

23 de jan. de 2025, 11:02 UTC

Ganhos

Elevance Health Sees 2025 Adj EPS $34.15-Adj EPS $34.85 >ELV

23 de jan. de 2025, 11:01 UTC

Ganhos

Elevance Health Sees 2025 EPS $30.40-EPS $31.10 >ELV

23 de jan. de 2025, 11:00 UTC

Ganhos

Elevance Health 4Q Benefit Expense Ratio 92.4% >ELV

23 de jan. de 2025, 11:00 UTC

Ganhos

Elevance Health 4Q Net $418M >ELV

23 de jan. de 2025, 11:00 UTC

Ganhos

Elevance Health 4Q EPS $1.81 >ELV

23 de jan. de 2025, 11:00 UTC

Ganhos

Elevance Health 4Q Rev $45.44B >ELV

23 de jan. de 2025, 11:00 UTC

Ganhos

Elevance Health 4Q Adj EPS $3.84 >ELV

23 de jan. de 2025, 11:00 UTC

Ganhos

Elevance Health 4Q Medical Enrollment Members 45.7M >ELV

16 de jan. de 2025, 17:29 UTC

Ganhos

Healthcare Stocks Fall After UnitedHealth Posts Higher Medical Costs -- WSJ

10 de dez. de 2024, 10:56 UTC

Principais Notícias

Luigi Mangione Charged With Murder of UnitedHealthcare CEO. He Was Carrying a Ghost Gun. -- Barrons.com

5 de dez. de 2024, 23:00 UTC

Principais Notícias

Anthem Backs Off Plans to Deny Anesthesia Claims After Public Backlash -- Barrons.com

5 de dez. de 2024, 22:15 UTC

Principais Notícias

Anthem Backs Off Plans to Deny Anesthesia Claims After Public Backlash -- Barrons.com

20 de nov. de 2024, 07:00 UTC

Aquisições, Fusões, Aquisições de Empresas

This Winning Fund Has a Plan to Sell Nvidia Stake. What It's Waiting For. -- Barrons.com

21 de out. de 2024, 17:45 UTC

Ganhos

Correction to Heard on the Street Article About Health Insurers -- WSJ on Oct. 19

19 de out. de 2024, 11:00 UTC

Principais Notícias
Ganhos

Why Do Health Insurers Keep Getting Slammed With Higher Costs? -- Heard on the Street -- WSJ

18 de out. de 2024, 20:59 UTC

Aquisições, Fusões, Aquisições de Empresas

An Elevance Health Exec Canceled His Plan to Sell Stock Weeks Before the Plunge -- Barrons.com

17 de out. de 2024, 16:31 UTC

Ganhos

Taiwan Semiconductor Leads Chip Stocks Higher; Dow Jones Thrusts To New Highs As This Industry Group Leads (LiveCoverage) -- IBD

17 de out. de 2024, 15:37 UTC

Ganhos

Elevance's Results Spark Managed-Care Selloff. Outlook Sours for Health Insurers. -- Barrons.com

17 de out. de 2024, 14:16 UTC

Principais Notícias
Ganhos

Elevance Shares Dive After Insurer Faces 'Unprecedented' Medicaid Challenge -- Update

17 de out. de 2024, 12:57 UTC

Principais Notícias

Elevance Shares Dive After Insurer Faces 'Unprecedented' Medicaid Challenge -- WSJ

17 de out. de 2024, 12:50 UTC

Ganhos

Elevance Stock Dives on Guidance Cut. Blame 'Unprecedented Challenges' in Medicaid Business. -- Barrons.com

17 de out. de 2024, 11:35 UTC

Ganhos

Elevance Stock Dives on Guidance Cut. Blame 'Unprecedented Challenges' in Medicaid Business. -- Barrons.com

17 de out. de 2024, 10:01 UTC

Ganhos

Elevance Health Sees 2024 Adj EPS $33 >ELV

Comparação entre Pares

Variação de preço

Elevance Health Inc Previsão

Preço-alvo

By TipRanks

10.03% parte superior

Previsão para 12 meses

Média 476.07 USD  10.03%

Máximo 585 USD

Mínimo 405 USD

Com base em 15 analistas de Wall Street que oferecem metas de preço de 12 meses para Elevance Health Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

15 ratings

12

Comprar

3

Manter

0

Vender

Sentimento

By Acuity

130 / 386 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Elevance Health Inc

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.